Production (Stage)
QIAGEN N.V.
QGEN
$44.38
$0.531.21%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.31% | 0.66% | 0.62% | -1.90% | -2.99% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.31% | 0.66% | 0.62% | -1.90% | -2.99% |
| Cost of Revenue | 44.54% | 40.90% | 44.38% | 42.59% | -0.40% |
| Gross Profit | -17.84% | -20.04% | -21.47% | -24.04% | -4.27% |
| SG&A Expenses | -1.17% | -2.56% | -3.20% | -4.17% | -4.74% |
| Depreciation & Amortization | -13.94% | -9.10% | -7.31% | -2.73% | -0.51% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.79% | 16.21% | 17.14% | 16.35% | -2.25% |
| Operating Income | -45.87% | -52.43% | -56.77% | -63.26% | -5.44% |
| Income Before Tax | -67.30% | -71.81% | -72.61% | -76.36% | -0.60% |
| Income Tax Expenses | -48.21% | -57.57% | -74.80% | -67.13% | 18.43% |
| Earnings from Continuing Operations | -72.20% | -75.51% | -72.05% | -78.43% | -4.53% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -72.20% | -75.51% | -72.05% | -78.43% | -4.53% |
| EBIT | -45.87% | -52.43% | -56.77% | -63.26% | -5.44% |
| EBITDA | -34.28% | -37.07% | -39.09% | -43.96% | -3.94% |
| EPS Basic | -72.73% | -76.00% | -72.55% | -78.83% | -5.02% |
| Normalized Basic EPS | -43.21% | -49.92% | -52.06% | -58.41% | -2.79% |
| EPS Diluted | -73.45% | -76.35% | -72.95% | -79.25% | -4.99% |
| Normalized Diluted EPS | -43.22% | -50.02% | -52.18% | -58.59% | -2.74% |
| Average Basic Shares Outstanding | 0.31% | 0.54% | 0.53% | 0.49% | 0.47% |
| Average Diluted Shares Outstanding | -0.10% | 0.23% | 0.22% | 0.24% | 0.49% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |